Jazz Pharmaceuticals and Gentium announce Europcean launch of Defitelio

Jazz Pharmaceuticals and Gentium announce Europcean launch of Defitelio Jazz Pharmaceuticals and Gentium S.p.A., a Jazz Pharmaceuticals company, announced the commencement of the European commercial launch of Defitelio, the first licensed product for the treatment of severe hepatic veno-occlusive disease in patients over one month of age undergoing ... (more)

http://ift.tt/1khxOkB